Abstract
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cutaneous melanoma have been significantly revised over the past few years in response to emerging data on immune checkpoint inhibitor therapies and BRAF-targeted therapy. This article summarizes the data and rationale supporting extensive changes to the recommendations for systemic therapy as adjuvant treatment of resected disease and as treatment of unresectable or distant metastatic disease.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 367-402 |
| Number of pages | 36 |
| Journal | JNCCN Journal of the National Comprehensive Cancer Network |
| Volume | 17 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 2019 |
Fingerprint
ASJC Scopus subject areas
- Oncology
Cite this
Cutaneous melanoma, version 2.2019. / Coit, Daniel G.; Thompson, John A.; Albertini, Mark R.; Barker, Christopher; Carson, William E.; Contreras, Carlo; Daniels, Gregory A.; DiMaio, Dominick; Fields, Ryan C.; Fleming, Martin D.; Freeman, Morganna; Galan, Anjela; Gastman, Brian; Guild, Valerie; Johnson, Douglas; Joseph, Richard W.; Lange, Julie R.; Nath, Sameer; Olszanski, Anthony J.; Ott, Patrick; Gupta, Aparna Priyanath; Ross, Merrick I.; Salama, April K.; Skitzki, Joseph; Sosman, Jeffrey; Swetter, Susan M.; Tanabe, Kenneth K.; Wuthrick, Evan; McMillian, Nicole R.; Engh, Anita M.
In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 17, No. 4, 04.2019, p. 367-402.Research output: Contribution to journal › Review article
}
TY - JOUR
T1 - Cutaneous melanoma, version 2.2019
AU - Coit, Daniel G.
AU - Thompson, John A.
AU - Albertini, Mark R.
AU - Barker, Christopher
AU - Carson, William E.
AU - Contreras, Carlo
AU - Daniels, Gregory A.
AU - DiMaio, Dominick
AU - Fields, Ryan C.
AU - Fleming, Martin D.
AU - Freeman, Morganna
AU - Galan, Anjela
AU - Gastman, Brian
AU - Guild, Valerie
AU - Johnson, Douglas
AU - Joseph, Richard W.
AU - Lange, Julie R.
AU - Nath, Sameer
AU - Olszanski, Anthony J.
AU - Ott, Patrick
AU - Gupta, Aparna Priyanath
AU - Ross, Merrick I.
AU - Salama, April K.
AU - Skitzki, Joseph
AU - Sosman, Jeffrey
AU - Swetter, Susan M.
AU - Tanabe, Kenneth K.
AU - Wuthrick, Evan
AU - McMillian, Nicole R.
AU - Engh, Anita M.
PY - 2019/4
Y1 - 2019/4
N2 - The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cutaneous melanoma have been significantly revised over the past few years in response to emerging data on immune checkpoint inhibitor therapies and BRAF-targeted therapy. This article summarizes the data and rationale supporting extensive changes to the recommendations for systemic therapy as adjuvant treatment of resected disease and as treatment of unresectable or distant metastatic disease.
AB - The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cutaneous melanoma have been significantly revised over the past few years in response to emerging data on immune checkpoint inhibitor therapies and BRAF-targeted therapy. This article summarizes the data and rationale supporting extensive changes to the recommendations for systemic therapy as adjuvant treatment of resected disease and as treatment of unresectable or distant metastatic disease.
UR - http://www.scopus.com/inward/record.url?scp=85064408797&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064408797&partnerID=8YFLogxK
U2 - 10.6004/jnccn.2019.0018
DO - 10.6004/jnccn.2019.0018
M3 - Review article
C2 - 30959471
AN - SCOPUS:85064408797
VL - 17
SP - 367
EP - 402
JO - JNCCN Journal of the National Comprehensive Cancer Network
JF - JNCCN Journal of the National Comprehensive Cancer Network
SN - 1540-1405
IS - 4
ER -